Genome sequences of multidrug-resistant, colistin-susceptible and -resistant Klebsiella pneumoniae clinical isolates from Pakistan by Crawford, Matthew A. et al.
Genome Sequences of Multidrug-Resistant, Colistin-Susceptible and
-Resistant Klebsiella pneumoniae Clinical Isolates from Pakistan
Matthew A. Crawford,a Ruth Timme,b Sara Lomonaco,b Christine Lascols,c Debra J. Fisher,a Shashi K. Sharma,b Errol Strain,b
Marc W. Allard,b Eric W. Brown,b Melinda A. McFarland,b Tim Croley,b Thomas S. Hammack,b Linda M. Weigel,c Kevin Anderson,d
David R. Hodge,d Segaran P. Pillai,e Stephen A. Morse,c Erum Khan,f Molly A. Hughesa
Division of Infectious Diseases & International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USAa; Center for Food Safety & Applied
Nutrition, U.S. Food & Drug Administration, College Park, Maryland, USAb; National Center for Emerging and Zoonotic Diseases, Centers for Disease Control & Prevention,
Atlanta, Georgia, USAc; Science and Technology Directorate, U.S. Department of Homeland Security, Washington, DC, USAd; Office of the Commissioner, U.S. Food & Drug
Administration, Silver Spring, Maryland, USAe; Department of Pathology and Microbiology, Aga Khan University, Karachi, Pakistanf
The emergence and spread of colistin resistance among multidrug-resistant (MDR) Klebsiella pneumoniae represent a critical
threat to global health. Here, we report the complete genome sequences of 10 MDR, colistin-susceptible and -resistant K. pneu-
moniae clinical isolates obtained in Pakistan between 2010 and 2013.
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Klebsiella pneumoniae is a Gram-negative bacterial pathogenthat causes a range of clinical diseases including pneumonia,
bacteremia, and wound and urinary tract infections. The continu-
ing increase of antibiotic resistance in K. pneumoniae presents a
considerable challenge to global health. In particular, carbapen-
emase and/or extended spectrum -lactamase production by this
important human pathogen greatly limits therapeutic options and
is associated with frequent treatment failures and increased mor-
tality (1). The serious challenge posed by multidrug-resistant
(MDR) K. pneumoniae has been countered by the clinical use of
colistin (CST), a decades-old polymyxin considered to be the last
line of defense against infections caused by MDR Gram-negative
bacterial pathogens. Unfortunately, reports of CST-resistant
K. pneumoniae are becoming increasingly common, and surveil-
lance studies have demonstrated an increase in the prevalence of
CST resistance (2). Infections caused by MDR, CST-resistant
K. pneumoniae are of great concern as there are no suitable ther-
apeutic agents available to treat them.
Here, we report the whole-genome sequences for 10 MDR
K. pneumoniae strains isolated from patients in Pakistan between
2010 and 2013. Among these strains, seven are CST resistant and
three are CST susceptible as determined using the Vitek 2 system
(bioMérieux, Marcy l’Etoile, France) and by disk diffusion. These
data provide a comparative genetic context for CST resistance in
K. pneumoniae that will inform infectious diseases epidemiology
and the identification of antimicrobial resistance determinants.
Importantly, such information is likely to be broadly applicable to
CST resistance among Enterobacteriaceae.
DNA libraries were prepared using the Nextera XT DNA li-
brary preparation kit (Illumina, San Diego, CA, USA), and whole-
genome sequencing was performed on an Illumina MiSeq system
using MiSeq reagent kit v2 (2 250 bp paired-end reads).De novo
genome assemblies were created using SPAdes Genome Assem-
bler and evaluated in comparison to the genome ofK. pneumoniae
HS11286 (3) using the quality assessment tool QUAST (4). As-
sembled genomes were annotated using the National Center
for Biotechnology Information (NCBI) Prokaryotic Genome
Annotation Pipeline (https://www.ncbi.nlm.nih.gov/genome/
annotation_prok/). Multi-locus sequence typing (MLST) was
performed according to the scheme described for the Institut
Pasteur K. pneumoniae database (http://bigsdb.pasteur.fr/
klebsiella/klebsiella.html). The presence of NDM-1 and/or
OXA-48 -lactamases was determined by PCR and confirmed us-
ing whole-genome sequencing data. The presence of NDM-1
and/or OXA-48, CST resistance, and sequence type (ST) are indi-
cated for each strain: BA2880 (OXA-48, CSTR, ST101), BA3783
(NDM-1 and OXA-48, CSTR, ST14), BL13802 (NDM-1 and
OXA-48, CSTS, ST11), BA2664 (OXA-48, CSTR, ST11), BL8800
(OXA-48, CSTR, ST101), BL12456 (NDM-1, CSTS, ST14), BL849
(NDM-1, CSTR, ST11), BU19801 (NDM-1, CSTR, ST307), MS84
(NDM-1, CSTR, ST15), BL12125 (NDM-1, CSTS, ST14).
Accession number(s). The genome assemblies described in this
manuscript are available in DDBJ/ENBL/GenBank under the ac-
cession numbers MAGC00000000 (BA2880), MAGE00000000
(BA3783), MAGF00000000 (BL13802), MAGG00000000 (BA2664),
MAGH00000000 (BL8800), MAGI00000000 (BL12456),
MAGJ00000000 (BL849), MAGK00000000 (BU19801),
MAGL00000000 (MS84), and MAGM00000000 (BL12125).
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